JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258435

Human GMPR (GMPR1) knockout A549 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

GMPR KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 74 bp deletion in exon4.

View Alternative Names

GMP reductase 1, GMPR1_HUMAN, Gmpr, Guanosine 5' monophosphate oxidoreductase 1, Guanosine 5''-monophosphate oxidoreductase 1, Guanosine monophosphate reductase 1, guanosine monophosphate reductase

1 Images
Sanger Sequencing - Human GMPR (GMPR1) knockout A549 cell lysate (AB258435)
  • Sanger seq

Unknown

Sanger Sequencing - Human GMPR (GMPR1) knockout A549 cell lysate (AB258435)

Homozygous : 74 bp deletion in exon4

Key facts

Cell type

A549

Species or organism

Human

Tissue

Lung

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 74 bp deletion in exon4.

Disease

Carcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258435-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human GMPR knockout A549 cell lysate", "number":"AB258435-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type A549 cell lysate", "number":"AB258435-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
GMPR
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The GMPR1 protein also known as guanosine monophosphate reductase 1 acts mechanistically as an enzyme that catalyzes the conversion of guanosine monophosphate (GMP) to inosine monophosphate (IMP). This reaction is part of the purine nucleotide cycle important for maintaining the balance of nucleotide pools in cells. GMPR1 has a molecular mass of approximately 37 kDa. Expression of GMPR1 is detected in various tissues with significant levels present in liver and kidney tissues.
Biological function summary

GMPR1 plays a critical role in purine metabolism by regulating the intracellular concentrations of guanine nucleotides. It does not work as part of a larger complex but functions independently to achieve its effects on nucleotide turnover. This protein ensures efficient recycling of guanine nucleotides which is important for cellular processes such as DNA and RNA synthesis signalling and energy metabolism.

Pathways

GMPR1 is involved mainly in the purine salvage pathway and the nucleotide degradation pathway. Through these pathways GMPR1 links with other proteins like hypoxanthine-guanine phosphoribosyltransferase (HGPRT) which also participates in nucleotide salvage. The balance achieved in these pathways is essential for cellular proliferation and energy conservation highlighting GMPR1's role in overall cellular homeostasis.

GMPR1 has connections to conditions like gout and certain types of cancer where there is an imbalance in purine metabolism. The misregulation of GMPR1 potentially affecting the pathways it participates in may lead to excess uric acid production seen in gout or altered nucleotide metabolism in tumorigenesis. Additionally proteins such as HGPRT which interacts within the same purine pathways also exhibit associations with these disorders further illustrating the significant impact of purine metabolism in human health.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com